Papua New Guinea - Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases
Since 2014, Papua New Guinea Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases increased 12.6% year on year. In 2019, the country was number 61 comparing other countries in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases at 580 Cases. Papua New Guinea is overtaken by Djibouti, which was number 60 with 608 Cases and is followed by Zimbabwe with 565 Cases. India topped the ranking with 66,255 Cases in 2019, that is an increase of 13.6% versus 2018. India, Russia and Russia respectively ranked number 2, 3 and 4 in this ranking. Republic of the Congo recorded the best 5 years average growth at +171.1% per year, while Croatia recorded the worst performance at -100% per year.
Loading...
| Date | Units (Cases) |
|---|---|
| 2019 | 580.00 |
| 2018 | 433.00 |
| 2017 | 356.00 |
| 2016 | 342.00 |
| 2015 | 254.00 |
How does Papua New Guinea rank in Number of Confirmed Rifampicina Resistant/Multi-Drug Resistant Tuberculosis (RR-/MDR-TB) Cases?
| # | 359 Countries | Units (Cases) | Last | YoY | 5‑years CAGR | ||
|---|---|---|---|---|---|---|---|
| 1 |
#1
India
|
66,255 | 2019 | +13.6 % | +20.8 % | View data | |
| 3 |
#3
Russia
|
29,181 | 2019 | +5.0 % | +13.4 % | View data | |
| 60 |
#60
Djibouti
|
608 | 2019 | +807.5 % | +40.8 % | View data | |
| 61 |
#61
Papua New Guinea
|
580 | 2019 | +34.0 % | +12.6 % | View data | |
| 62 |
#62
Zimbabwe
|
565 | 2019 | +5.2 % | +6.5 % | View data | |